Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +10,081 $78.57 $792K 375,163
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +11,060 $79.70 $881K 386,223
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +3,884 $80.33 $312K 390,107
2023-11-03 INGRAM DOUGLAS S President & CEO Purchase +200 $81.26 $16K 390,307
2021-11-17 INGRAM DOUGLAS S President & CEO Purchase +25,026 $79.94 $2.0M 365,082
2019-08-12 INGRAM DOUGLAS S President & CEO Purchase +8,460 $122.76 $1.0M 424,405
2019-08-12 INGRAM DOUGLAS S President & CEO Purchase +7,792 $123.41 $962K 432,197
2018-10-30 INGRAM DOUGLAS S President & CEO Purchase +13,561 $120.26 $1.6M 412,811
2018-10-30 INGRAM DOUGLAS S President & CEO Purchase +3,134 $120.94 $379K 415,945
2018-08-15 INGRAM DOUGLAS S President & CEO Purchase +16,000 $125.26 $2.0M 399,250
2017-11-08 INGRAM DOUGLAS S President & CEO Purchase +38,138 $52.44 $2.0M 420,196

Page 1 of 1 · 11 trades